id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-325070-583innd7	Lee, Lennard Y.W.	Utility of COVID-19 Screening in Cancer Patients	2020-07-24		.txt	text/plain	1121	61	41	We conclude that where the incidence of asymptomatic infection is low and patients can be identified early, screening enables the confidence to safely deliver effective cancer care in the era of COVID-19. Patients with cancer are at increased risk of contracting SARS-CoV-2 and have a high mortality rate from COVID-19 (Lee et al., 2020) . A number of national and international cancer guidelines now advise the screening of every patient undergoing chemotherapy to enable early identification and isolation of patients with asymptomatic SARS-CoV-2 infections to prevent hospital transmission (https://www.idsociety.org/practice-guideline/covid-19-guidelinediagnostics/; https://www.rcr.ac.uk/sites/default/files/guidance-covid19-testing-asymptomatic-hcw-patientsoncology.pdf; https://www.asco.org/sites/new-www.asco.org/files/content-files/2020-ASCO-Guide-Cancer-COVID19.pdf). Our cohort demonstrates that uptake for screening of SARS-CoV-2 through nasopharyngeal testing is high in cancer patients. We conclude that where the incidence of asymptomatic infection is low and patients can be identified early, screening enables the confidence to safely deliver effective cancer care; this will be monitored as the pandemic evolves. Screening for COVID-19 in asymptomatic patients with cancer in a hospital in the United Arab Emirates	./cache/cord-325070-583innd7.txt	./txt/cord-325070-583innd7.txt